Prostate Cancer
Recent Abstracts
Salvage radiotherapy in patients with persistently detectable PSA or PSA rising from an undetectable range after radical prostatectomy gives comparable results - Abstract
May 23, 2012
Transdermal estradiol in castrate and chemotherapy resistant prostate cancer - Abstract
May 23, 2012
Thirty years of research on infection and prostate cancer: No conclusive evidence for a link. A systematic review - Abstract
May 23, 2012
Intraductal carcinoma of the prostate - Abstract
May 23, 2012
Implications of the International Society of Urological Pathology modified Gleason grading system - Abstract
May 23, 2012
Using circulating tumor cells as a prognostic indicator in metastatic castration-resistant prostate cancer - Abstract
May 23, 2012
Brachytherapy for prostate cancer does not influence long-term depression rate - Abstract
May 23, 2012
Review: Psychosocial interventions addressing sexual or relationship functioning in men with prostate cancer - Abstract
May 23, 2012
AUA 2012 - Perspectives from the AUA - PSA controversy: Do the harms exceed the benefits or the benefits exceed the harms? - A take-away message for urologists
May 23, 2012
AUA 2012 - Using social media to gauge reaction to the United States Preventive Services Task Force’s (USPSTF) report: Twitter as an investigative tool - Session Highlights
May 23, 2012
AUA 2012 - Prostate cancer diagnosis in patients receiving unrelated urologic care: Overdiagnosis or appropriate care? - Poster
May 23, 2012
AUA 2012 - Male pattern baldness may be a predictor of prostate cancer - Press Release
May 23, 2012
AUA 2012 - Evidence suggests statin use may slow prostate growth - Press Release
May 23, 2012
Quality of life in men receiving radiotherapy and neo-adjuvant androgen deprivation for prostate cancer: Results from a prospective longitudinal study - Abstract
May 22, 2012
AUA 2012 - Androgen biosynthesis inhibition and metastatic castration-resistant prostate cancer - Exclusive Interview
May 22, 2012
Long-term oncological outcome and risk stratification in men with high-risk prostate cancer treated with radical prostatectomy - Abstract
May 22, 2012
The efficacy and safety of degarelix, a GnRH antagonist: A 12-month, multicentre, randomized, maintenance dose-finding Phase II study in Japanese patients with prostate cancer - Abstract
May 22, 2012
AUA 2012 - Group seminars are an effective and economic method of delivering patient information regarding radical prostatectomy and functional outcomes - Session Highlights
May 22, 2012
AUA 2012 - The changing "landscape" of clinical T3 prostate cancer - Session Highlights
May 22, 2012
AUA 2012 - Abiraterone acetate (an androgen biosynthesis inhibitor) in patients with metastatic castration-resistant prostate cancer - Slide Presentation
May 22, 2012
Page 1262 of 1407
Start
Prev
1257
1258
1259
1260
1261
1262
1263
1264
1265
1266
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free